INVO Bioscience (OTC: IVOB.OB) Investor Report
March 22nd, 2010 at 10:38 am Posted by
If you haven’t noticed the press release out on TransworldNews.com, The Dean submitted a release this morning announcing that a special investor report on $IVOB has been published on CollegeStock.
The Dean wants all of his students to take a look at this investor report, which can be downloaded HERE.
Here’s a preview of what you can expect to find inside The Dean’s investor report on $IVOB:
The American Society for Reproductive Medicine (ASRM) considers a marriage barren or infertile when pregnancy has not occurred after a year of intercourse without contraception. For centuries, women around the world have been faced with ostracism, cultural backlash and negative stigmas attached to the inability to conceive and give birth to a child. Infertility places a large strain on women and married couples because it toys with our natural instinct as human beings to procreate and raise a family.
Some may view this as constant, growing problem within the human condition, while others in the field of medicine and biotechnology have taken matters into their own hands. In fact, it’s quite interesting that something so primal has just started to turn into a bull market.
According to ASRM’s 2004 figures for the infertility treatment market in the United States, infertility drugs made up 46% of the total market, while in vitro fertilization (IVF) came in as a close second, accounting for 36% of the $3 billion market. But, that was several years ago and many things in the medical field have changed.
The Dean believes this report will put things into perspective for $IVOB shareholders and newcomers alike. Download and read The Dean’s report HERE, to find out why The Dean calls $IVOB The Billion Dollar Baby.
